Polar Capital Biotech S Inc

Morningstar Rating™(Relative to Category)31/03/2024
 Morningstar ReturnMorningstar RiskMorningstar Rating™
3-YearHighAverage5 star
5-YearHighAbove Average5 star
10-YearHighAverage5 star
OverallHighAverage5 star
 
Click here to see our Methodology
Volatility Measurements31/03/2024
 
3-Yr Std Dev17.75 %
3-Yr Mean Return11.27 %
 
3-Yr Sharpe Ratio0.54
 
Modern Portfolio Statistics31/03/202431/03/2024
 Standard IndexBest Fit Index
 Morningstar Gbl Biotechnology NR USD  Morningstar Gbl Biotechnology NR USD
3-Yr Beta0.960.96
3-Yr Alpha1.261.26
 
Advertisement
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures